Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

AZ loses Pulmicort Respules protection in US

AZ loses Pulmicort Respules protection in US invalidated. Generic drugmaker Actavis responded to the ruling by immediately launching its own version of the Pulmicort Respules (budesonide), an inhalation suspension formulation of the corticosteroid that is used as a ... AZ has been fighting to

Deal Watch table for January 2015

Deal Watch table for January 2015 Asset acquisition. 470. Auden Mckenzie/Actavis. Purchase includes generic portfolio of 175 products making Actavis no 1 generic supplier in the UK.

Pharma deals during January 2015

Pharma deals during January 2015 Valued at $458m, this cash deal gives Actavis access to some 175 products but excludes any real estate. ... This deal was of significance to Actavis as it gives the company the number 1 position for generics in the UK.

AZ adds to respiratory portfolio with Actavis drugs

AZ adds to respiratory portfolio with Actavis drugs The Actavis deal adds two drugs for COPD to AZ's growing respiratory business. ... Actavis will also receive royalties once sales of the COPD drugs reach a certain threshold.

Valeant lead bidder for troubled Dendreon

Valeant lead bidder for troubled Dendreon However, Allergan resisted Valeant's advances for several months and eventually ended them in November last year after agreeing a $66bn deal with Actavis.

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics